Decision-pack review · Decision-Ready Evidence Dossier
What can the decision owner reasonably rely upon now, and what cannot be established?
The buyer’s decision
Buyer: Private-equity diligence teams, insurers, general counsel, business owners. Decision trigger: Allegation, material adverse media, funding event, executive change.
Defined unit: One defined commercial decision, six critical questions, specified sources and no unlimited investigation.
Research emphasis: Trace original allegations to proceedings and filings, reconcile linked entities, and record counterevidence.. Records prioritised include court docket, company filing, original allegation.
Exactly what is investigated
- Confirm exact subject, legal identity and the limited research period
- Recover the agreed original records and record publication, effective and collection dates
- Which dated original court docket most directly proves the key assertion concerning decision-ready evidence dossier?
- Could identity collision alter the proposed decision, and which record would disprove it?
- Test adverse or alternative evidence and distinguish absence of evidence from a negative finding
- Construct a traceable right-of-reply note for this decision
- Record the specific unavailable evidence and clarify what would change the conclusion
Deliverable and quality control
- Executive decision memo, evidence/contradiction matrix, dated primary-source index and recommendations for further questions.
- right-of-reply note using traceable sources
- Dated and classified findings: supported, contradicted, unresolved or out of scope
- Human review of source-to-claim traceability and privacy considerations
- Concisely stated reliance limitations and decision-owner questions
Boundary, cost and acceptance
Commercial rule: Fixed scope and fixed fee agreed in writing, with human acceptance before work begins. A fee amount is not yet approved for publication. No automatic checkout, blanket monitoring commitment, performance guarantee or prepaid credits.
- Balanced treatment, privacy minimisation and right of reply; no private-investigator powers claimed.
- Unlimited records, new jurisdictions, third-party licensed datasets and urgent handling unless contracted
- Final legal, accounting, medical, security, engineering, valuation or regulated sign-off
For a faster decision, commission the narrowest product that can resolve the immediate evidence question. Larger dossiers are optional and should follow a documented need.
Evidence starting points and what they do not prove
These databases and materials are starting points only. We do not claim that a named buyer, project, company or occurrence has been verified on this page.
- U.S. SEC EDGAR public filings Official or industry source for use if relevant, not evidence of a named case
- Kroll investigations & diligence services Official or industry source for use if relevant, not evidence of a named case
Written commissioning
Request Decision-pack review · Decision-Ready Evidence Dossier Choose your decision stageDefined evidence, not an unlimited research engagement
Decision-specific checks
- Which integrity claims are established, merely alleged or contradicted?
- Independent contrary-source check and named source version/date
- Explicit not-observed / outside-mandate decision
What to provide
- Exact subject identifier and jurisdiction
- Decision date, quoted claim or document
- Permitted supporting evidence and known contrary claims
Illustrative delivery components
Executive memo and source annex and a source index stating record ID, issuer, effective date, read date and unresolved matters.
Professional reliance limit
Balanced treatment, privacy minimisation and right of reply; no private-investigator powers claimed.
Illustrative specification only. No factual conclusion or cleared buyer has been represented. Written scope, fee and researcher acceptance are required.
Evidence before commitment · clearly bounded
A specific answer for a specific decision
What can a board fairly rely upon now?
What the review checks
- Record the precise named subject, stable identifier, period and claim being tested.
- Recover or request issuer-side corrective statements and subject responses and distinguish the original issuer from a vendor-generated summary.
- Test the adverse possibility that material defence, dismissal or exculpatory fact absent from a narrative.
- State what cannot be established, rather than quietly converting a failed search into an exculpatory finding.
- Obtain independent human source traceability review and identify the client professional responsible for final reliance.
What you supply
- Named company or matter, relevant legal entity identifiers, jurisdiction and decision date.
- Up to the stated cap of quoted claims and original client-held documents available lawfully.
- Known alternatives, exculpatory evidence and material contrary accounts.
- Written approval of bounded deliverable, reuse/reliance limits, any paid-source costs and a human reviewer.
A human-reviewed source and contradiction assessment. No general AI answer is accepted as independent evidence. Scope, actual source availability, exclusions, fixed fee and delivery date are agreed in writing before work begins.
This specimen describes the method and possible deliverables. It is not a completed client investigation and contains no case findings.
